Amylase and Lipase Test in Delhi

Amylase + Lipase Test at Home (Pancreatic Enzyme Blood Test)

The Amylase + Lipase combination blood test is the standard biochemical panel for evaluating pancreatic health. Both amylase and lipase are digestive enzymes produced by the pancreas. When the pancreas becomes inflamed or damaged, these enzymes leak into the bloodstream in significantly elevated quantities, making their measurement a reliable indicator of pancreatic injury.

Ordering both markers together is a deliberate clinical strategy. Amylase rises fast and returns to normal quickly. Lipase rises more slowly but stays elevated for much longer. Together, they cover the full diagnostic window regardless of when the patient presents for testing.

MAX@Home brings this panel directly to your home. A certified phlebotomist collects your blood sample at a time you choose, and your report is delivered digitally through an accredited partner laboratory.

What Amylase Measures

Amylase is a digestive enzyme that breaks down complex carbohydrates, including starch and glycogen, into simpler sugars. It is produced by two main sources: the pancreas and the salivary glands. Under normal conditions, only small amounts enter the bloodstream.

When the pancreas is inflamed, the ductal architecture is disrupted and amylase leaks into the blood, causing a sharp rise in serum levels, often within 6 to 12 hours of the onset of symptoms.

Key facts about amylase

• Serum amylase rises 6 to 12 hours after pancreatic injury begins.
• It typically returns to normal within 3 to 5 days, even if the patient is still unwell.
• Because salivary glands also produce amylase, an elevated reading is not automatically evidence of pancreatic disease.
• A condition called macroamylasaemia can cause persistently elevated amylase without any pancreatic problem.
• In acute pancreatitis, amylase typically rises to three times or more the upper limit of normal.

Pancreatic amylase versus salivary amylase

The total serum amylase measured by the standard test is the sum of both pancreatic and salivary isoforms. When clinical suspicion for pancreatic disease is moderate and the total amylase is only mildly elevated, laboratories can fractionate the result to measure pancreatic amylase separately. This helps distinguish true pancreatic inflammation from salivary gland disorders such as parotitis or from the benign condition of macroamylasaemia. In acute pancreatitis presentations, total amylase elevation to three times the upper limit of normal is considered sufficient for biochemical diagnosis without fractionation.

What Lipase Measures

Lipase is an enzyme that breaks down dietary fats into fatty acids and glycerol, enabling fat absorption in the small intestine. Unlike amylase, lipase is produced almost exclusively by the pancreas. This organ specificity makes it a significantly more reliable marker of pancreatic injury.

Lipase rises more slowly than amylase, typically peaking 24 to 48 hours after the onset of symptoms, but it remains elevated for up to 14 days, making it particularly useful in patients who present late.

Key facts about lipase

• Lipase is more specific to the pancreas than amylase, with fewer non-pancreatic causes of elevation.
• It remains elevated for up to 14 days, far longer than amylase's 3 to 5 days.
• In acute pancreatitis, lipase elevated to three times or more the upper limit of normal is the strongest single biochemical indicator.
• Lipase is the preferred marker in patients who present more than 24 to 48 hours after symptom onset.
• Kidney disease can also raise lipase levels due to impaired renal clearance, so clinical context is always needed.

Why lipase has replaced amylase as the preferred single marker

In settings where only one enzyme can be ordered, most contemporary clinical guidelines recommend lipase over amylase because of its superior sensitivity and specificity for pancreatic disease and its longer elevation window. However, ordering both together remains the best approach when the timing of symptom onset is uncertain or when a patient presents early in the course of illness before lipase has reached its peak. The combination also allows clinicians to detect the pattern of one enzyme rising while the other normalises, which has diagnostic value in characterising the phase and evolution of the pancreatic event.

Why Test Amylase and Lipase Together

The two enzymes have a complementary time profile that makes them most powerful when used in combination.

• Amylase captures early presentations within the first 12 to 24 hours when lipase may not yet be significantly elevated.
• Lipase captures late presentations after the amylase has normalised, ensuring the diagnosis is not missed in patients who delay care.
• A normal lipase alongside an elevated amylase points toward non-pancreatic causes such as salivary gland disease, reducing unnecessary concern about the pancreas.
• Both markers elevated together to three times the upper limit of normal provides the highest diagnostic confidence for acute pancreatitis.
• Using both markers reduces the chance of a missed or delayed diagnosis compared to relying on either enzyme alone.

Conditions This Panel Evaluates

Acute Pancreatitis

Acute pancreatitis is the most common reason this panel is ordered. It is a sudden inflammatory condition of the pancreas, most often triggered by gallstones obstructing the common bile duct or by heavy alcohol use. Other triggers include high triglyceride levels, certain medications, abdominal trauma, autoimmune conditions, and infections.

Clinically, it presents with severe upper abdominal pain that often radiates to the back, accompanied by nausea, vomiting, and sometimes fever. Both amylase and lipase are expected to be significantly elevated, typically exceeding three times the upper limit of normal, providing biochemical confirmation of the clinical diagnosis.

Chronic Pancreatitis

In chronic pancreatitis, repeated inflammatory episodes progressively damage the pancreatic tissue, replacing it with fibrous scar tissue. During stable periods, enzyme levels may be only mildly elevated or even normal because the gland no longer has enough functional tissue to mount a large enzyme surge. The test remains useful during acute-on-chronic flares and for evaluating patients during symptomatic episodes.

Pancreatic Duct Obstruction

Obstruction of the pancreatic duct, whether by a gallstone, stricture, or tumour, can cause enzyme accumulation and elevation in the blood. Mild lipase elevation in a patient with abdominal symptoms and no other clear cause warrants imaging evaluation to rule out obstructive pathology including early pancreatic cancer.

Hypertriglyceridaemia-Induced Pancreatitis

Very high serum triglyceride levels, typically exceeding 1000 mg/dL, are an underrecognised but significant cause of acute pancreatitis. This form of pancreatitis tends to occur in individuals with familial hyperlipidaemia, uncontrolled diabetes, or those on medications that elevate triglycerides. Importantly, very high triglycerides can artificially suppress or mask the elevation of amylase and lipase in some laboratory assays, so clinical correlation remains essential. Patients with recurrent pancreatitis without an identified cause should have a fasting lipid profile reviewed.

Other Conditions That May Elevate These Enzymes

• Bowel obstruction or intestinal ischaemia (infarction) - can cause enzyme release from gut tissue.
• Perforated peptic ulcer - can cause secondary pancreatic irritation.
• Ectopic pregnancy - may elevate amylase in some cases.
• Diabetic ketoacidosis - associated with mild enzyme elevation without frank pancreatitis.
• Renal failure - impairs clearance of both enzymes, raising their blood levels even without pancreatic disease.
• Macroamylasaemia - causes persistently elevated amylase with a normal lipase, not a pancreatic condition.

Who Should Get the Amylase + Lipase Test

• Anyone with acute or recurring upper abdominal pain, especially pain radiating to the back.
• People with a history of gallstones when new abdominal symptoms arise.
• Individuals with heavy or prolonged alcohol use who develop abdominal discomfort or nausea.
• Patients with known high triglyceride levels or familial hyperlipidaemia.
• Those taking medications known to cause drug-induced pancreatitis, including certain diuretics, immunosuppressants, and antiretrovirals.
• Patients recovering from abdominal surgery or ERCP (endoscopic retrograde cholangiopancreatography) who develop pain or fever.
• Individuals with previously diagnosed pancreatitis who experience a recurrence of symptoms.

How to Prepare for Sample Collection

Fasting and timing

• A fasting period of 4 to 8 hours is generally recommended. Confirm specific requirements with your doctor.
• Early morning collection is often preferred to make fasting easier to manage.
• Avoid alcohol for at least 24 hours before the test.
• Inform your doctor of all medications you are taking, particularly any that may affect pancreatic enzyme levels.

Collection details

• Sample type: blood (serum).
• A certified MAX@Home phlebotomist visits at your scheduled time.
• Sterile, single-use equipment is used for every collection.
• Report turnaround: typically 24 hours from sample receipt at the accredited partner lab.

Important notes on urgent presentations

• If you are experiencing severe, sudden-onset upper abdominal pain, seek emergency evaluation immediately rather than scheduling a home test.
• Home testing is suitable for follow-up monitoring, mild or resolved symptoms, and non-acute presentations.
• In acute hospitalised pancreatitis, enzyme tests are typically done in-hospital as part of emergency assessment.

Understanding Your Amylase and Lipase Results

Amylase normal range

• Adults: approximately 23 to 85 units per litre (U/L); may vary slightly by laboratory.
• Levels three times or more the upper limit of normal are the threshold used for diagnosing acute pancreatitis biochemically.
• Mildly elevated amylase with a normal lipase often has a non-pancreatic explanation.

Lipase normal range

• Adults: approximately 0 to 160 U/L; specific range varies by laboratory platform.
• Lipase elevated to three times the upper limit of normal alongside compatible symptoms strongly supports acute pancreatitis.
• Persistent mild elevation of lipase warrants imaging evaluation even in the absence of acute symptoms.

Important caveats in result interpretation

The height of enzyme elevation does not reliably predict disease severity. A patient with only modestly elevated enzymes may have severe pancreatitis, while very high enzyme levels may be seen in mild self-limiting cases. Severity is assessed through clinical scoring systems, imaging, and organ function monitoring. All results should be interpreted by your treating physician alongside the full clinical picture.

What to do after an abnormal result

If either enzyme is significantly elevated and you are not already under medical care, contact your doctor promptly. Depending on your symptoms and the degree of elevation, your physician may arrange abdominal imaging such as an ultrasound or CT scan, liver function tests, a lipid profile, and renal function assessment. Serial enzyme measurements may be ordered to track the trend over time. Do not stop any prescribed medication or start any treatment on the basis of the enzyme results alone without medical guidance.

How to Book Your Amylase + Lipase Test with MAX@Home

1.  Open the MAX@Home website or app and search for the Amylase + Lipase test.

2.  Choose a date and time. If fasting is required, select an early morning slot.

3.  A certified phlebotomist arrives at your home with all necessary sterile equipment.

4.  The blood sample is collected and transported to the accredited partner laboratory.

5.  Your digitally authenticated report is delivered to your registered contact within 24 hours.

Why Choose MAX@Home for This Test

• Pancreatic symptoms are often painful and debilitating, making travel to a diagnostic centre an unnecessary burden. Home collection removes that barrier entirely.
• Phlebotomists are trained to handle enzyme-sensitive samples correctly from collection to transport.
• Accredited partner laboratories use validated analytical platforms that match the accuracy standards of hospital-grade diagnostics.
• Digitally authenticated reports are delivered securely and accessible from any device.
• For patients who need serial monitoring during recovery, home-visit testing avoids repeated clinic trips.